I am passionate about helping great teams realize exceptional outcomes.
Kyle provides mergers and acquisitions (M&A) advisory services to private equity and privately held and public companies across a variety of sectors in the healthcare industry.
Kyle builds close relationships with his clients, understanding their unique objectives and creatively positioning their businesses to achieve outlier results. He delivers thoughtful and strategic advice to drive a successful outcome for each transaction.
Prior to joining Lincoln, Kyle was an Associate on Baird’s healthcare investment banking team.
Kyle graduated from Indiana University with bachelor’s degrees in finance and accounting.
Recent Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Lincoln International advised EverVet Partners, a portfolio company of Tailwind Capital, on receiving a significant investment from Freeman Spogli & Co.
Meet our Senior Team
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt